Investor Relations

Investor Relations

Investor E-Mail Update Service Shareholder Update Global BuyDIRECT Request Investor Information Senetek Annual Reports View Annual Report 2000     View Annual Report 2001 With the free Adobe® Acrobat® ReaderTM, you can view and print Adobe PDF files.PLEASE NOTE: This site contains forward-looking…

Sexual Dysfunction

Sexual Dysfunction

Important advances for millions with sexual dysfunction. Invicorp® is a highly safe and effective treatment for erectile dysfunction (ED), a condition that affects more than 100 million men worldwide. Invicorp®, a combination of vasoactive intestinal peptide (VIP) and phentolamine mesylate (PMS),…

Innovative Technologies

Innovative Technologies

A unique portfolio of cutting-edge, commercially viable products. Senetek is focused on the development of advanced technologies and medical treatment breakthroughs in two therapeutic areas: anti-aging and sexual dysfunction. Anti-aging Skincare is one of the fastest-growing health-related markets representing approximately $56…

Management Profile

Management Profile

The security of solid corporate management. Frank J. Massino Chairman and CEO Mr. Massino became Chairman and CEO of Senetek PLC in November 1998. Drawing on his professional management experience at major corporations such as Glaxo, Ortho Pharmaceutical Corporation, Johnson & Johnson,…

Corporate Profile

senetekplc

Turning scientific discoveries into real-world success. Senetek PLC is a science-driven biopharmaceutical company engaged in the development of advanced treatments for sexual dysfunction and anti-aging. Senetek’sproprietary technologies have demonstrated significant advantages over competitive products and are positioned to make an important impact…